Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antagonist: population based endoscopic screening for colorectal cancer.

Literature DB >> 12584210

Antagonist: population based endoscopic screening for colorectal cancer.

D A L Macafee¹, J H Scholefield.

Abstract

Entities: Disease

Mesh：

Year: 2003 PMID： 12584210 PMCID： PMC1773563 DOI： 10.1136/gut.52.3.323

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

36 in total

1. Going the distance--the case for true colorectal-cancer screening.

Authors: D K Podolsky
Journal: N Engl J Med Date: 2000-07-20 Impact factor: 91.245

2. The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors: J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal: N Engl J Med Date: 2000-11-30 Impact factor: 91.245

Review 3. What can we conclude from the randomized controlled trials of fecal occult blood test screening?

Authors: C A Lang; D F Ransohoff
Journal: Eur J Gastroenterol Hepatol Date: 1998-03 Impact factor: 2.566

4. Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening.

Authors: K McCallion; R M Mitchell; R H Wilson; F Kee; R G Watson; J S Collins; K R Gardiner
Journal: Gut Date: 2001-04 Impact factor: 23.059

5. Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.

Authors: J N Lund; J H Scholefield; M J Grainge; S J Smith; C Mangham; N C Armitage; M H Robinson; R F Logan
Journal: Gut Date: 2001-07 Impact factor: 23.059

Review 6. Stool screening for colorectal cancer: evolution from occult blood to molecular markers.

Authors: David A Ahlquist; Anthony P Shuber
Journal: Clin Chim Acta Date: 2002-01 Impact factor: 3.786

Review 7. Screening for colorectal cancer using the faecal occult blood test, hemoccult.

Authors: B P Towler; L Irwig; P Glasziou; D Weller; J Kewenter
Journal: Cochrane Database Syst Rev Date: 2000

8. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.

Authors: P D Greenberg; L Bertario; R Gnauck; O Kronborg; J D Hardcastle; M S Epstein; D Sadowski; R Sudduth; G R Zuckerman; D C Rockey
Journal: Am J Gastroenterol Date: 2000-05 Impact factor: 10.864

9. Cost-effectiveness of screening for colorectal cancer in the general population.

Authors: A L Frazier; G A Colditz; C S Fuchs; K M Kuntz
Journal: JAMA Date: 2000-10-18 Impact factor: 56.272

10. Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Authors: A Sonnenberg; F Delcò; J M Inadomi
Journal: Ann Intern Med Date: 2000-10-17 Impact factor: 25.391

6 in total

Review 1. Screening tests for colorectal cancer: a menu of options remains relevant.

Authors: James E Allison; Michael Lawson
Journal: Curr Oncol Rep Date: 2006-11 Impact factor: 5.075

Review 2. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors: J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal: Gut Date: 2007-02 Impact factor: 23.059

Review 3. FIT testing: an overview.

Authors: Lukejohn W Day; Taft Bhuket; James Allison
Journal: Curr Gastroenterol Rep Date: 2013-11